Isofol Medical AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	55.74	41.99	96.16	138.15	190.53	379.45
Short-Term Investments	55	85	-	-	-	-
Cash & Short-Term Investments	110.74	126.99	96.16	138.15	190.53	379.45
Cash Growth	34.87%	32.06%	-30.40%	-27.49%	-49.79%	226.01%
Other Receivables	1.82	1.42	1.81	2.15	17.65	12.28
Total Trade Receivables	1.82	1.42	1.81	2.15	17.65	12.28
Other Current Assets	1.35	0.99	0.45	0.3	1.56	2.88
Total Current Assets	113.91	129.4	98.42	140.59	209.75	394.61
Net Property, Plant & Equipment	-	-	-	0	0.09	1.75
Other Long-Term Assets	-	-	-	-	0.05	5.01
Total Assets	113.91	129.4	98.42	140.6	209.89	401.36
Accounts Payable	2.09	2.73	2.03	1.99	7.87	17.74
Accrued Expenses	17.24	17.09	16.82	15.03	40.88	62.11
Other Current Liabilities	1.13	1.09	0.98	1.23	1.79	3.17
Total Current Liabilities	20.46	20.91	19.82	18.25	50.54	83.02
Long-Term Leases	-	-	-	-	-	0.11
Other Long-Term Liabilities	1.24	1.22	1.3	0.91	1.69	-
Total Long-Term Liabilities	1.24	1.22	1.3	0.91	1.69	0.11
Total Liabilities	21.08	21.52	20.47	19.16	51.39	83.13
Common Stock	8.61	8.61	4.95	4.95	4.95	4.95
Additional Paid-in Capital	1,299	1,299	1,218	1,218	1,218	1,218
Retained Earnings	-1,214	-1,199	-1,145	-1,102	-1,065	-904.32
Shareholders' Equity	92.83	107.87	77.94	121.43	158.5	318.23
Total Liabilities & Equity	113.91	129.4	98.42	140.6	209.89	401.36
Total Debt	-	0	0	0	0	0.11
Net Cash (Debt)	110.74	126.99	96.16	138.15	190.53	379.34
Net Cash Growth	-12.80%	32.06%	-30.40%	-27.49%	-49.77%	229.99%
Net Cash Per Share	0.48	0.58	0.59	0.85	1.18	3.02
Book Value	92.83	107.87	77.94	121.43	158.5	318.23
Book Value Per Share	0.40	0.50	0.48	0.75	0.98	2.53
Tangible Book Value	92.83	107.87	77.94	121.43	158.5	318.23
Tangible Book Value Per Share	0.40	0.50	0.48	0.75	0.98	2.53